|Molecular Vision 2002;
Received 17 December 2001 | Accepted 15 March 2002 | Published 22 March 2002
Cloning and characterization of the canine photoreceptor specific cone-rod homeobox (CRX) gene and evaluation as a candidate for early onset photoreceptor diseases in the dog
Novrouz B. Akhmedov,1 Victoria J. Baldwin,2 Barbara
Zangerl,2 James W. Kijas,2 Linda Hunter,2 Katayoun D.
Minoofar,1 Cathryn Mellersh,3 Elaine A. Ostrander,3
Gregory M. Acland,2 Debora B. Farber,1
Gustavo D. Aguirre2
(The first two authors contributed equally to this publication)
1Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA; 2James A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY; 3Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D4-100, P. O. Box 19024, Seattle, WA
Correspondence to: Gustavo Aguirre, James A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853; Phone: (607) 256-5620; FAX: (607) 256-5689; email: email@example.com
Purpose: The cone-rod homeobox protein (CRX) is a member of the homeodomain-containing protein family expressed in the retinal photoreceptors and pinealocytes; it is involved in the regulation of the coordinate expression of multiple photoreceptor specific genes during retinal development. Mutations in the CRX gene are causally associated with retinal degeneration phenotypes in man. To clone the full length cDNA, characterize the genomic organization of canine CRX, map the gene in a radiation hybrid (RH) panel, and evaluate it as a candidate for canine inherited retinal degenerations.
Methods: cDNA representational difference analysis (RDA) was done using normal and cone degeneration (cd) affected retinas. Exonic primers designed from consensus sequences of mammalian CRX cDNA were used to amplify and sequence dog genomic DNA. Canine specific primers were used for RH mapping of CRX on the RH3000 cell line. Linkage, sequencing and/or mapping the disease locus was used to evaluate CRX as a disease associated candidate gene.
Results: The gene comprises three exons and two introns and codes for a transcript with a 900 bp open reading frame (ORF). In agreement with human map data, RH mapping placed canine CRX on the proximal end of CFA1, in a region of synteny with HSA19q13-q13.3. Based on RH mapping, meiotic linkage or sequencing data, we excluded CRX as the cause of canine early onset photoreceptor degenerations affecting Alaskan malamutes (cd), collies (rod-cone dysplasia 2, rcd2), American Staffordshire terriers, and Tibetan terriers.
Conclusions: Canine CRX has a high level of nucleotide and amino acid sequence identity with ortholgous sequences reported for other species. The gene is excluded from causal association with 4 early onset photoreceptor diseases affecting cones (cd) or rods and cones (rcd2, PRA in American Staffordshire terriers, and Tibetan terriers).
The cone-rod homeobox protein (CRX) is a member of the homeodomain-containing protein family, and is expressed in retinal photoreceptors and pinealocytes [1,2]. As a transcription factor, CRX is involved in vertebrate eye development and plays an important role in gene expression. CRX binds to conserved sites of several photoreceptor specific genes in the retina, and transactivates their expression during photoreceptor differentiation and maturation. Microarray analysis of retinas from wild type and CRX-deficient mice has indicated that the expression of 10 out of 17 differentially expressed genes controlled by CRX are photoreceptor specific or photoreceptor enriched. All of these target genes contain consensus CRX-binding elements . Furthermore, both the leucine zipper domain of NRL (neural retinal leucine zipper) and the DBD2 and DBD3 domains of HMG I (Y) (non-histone chromosomal proteins high mobility group I (Y)) have been observed to act synergistically with CRX in the enhancement of expression of some photoreceptor specific genes. These interactions are crucial, for example, in the regulation of rhodopsin expression [4,5].
Because of its critical role in the early stages of photoreceptor development, CRX is an excellent candidate gene for early onset retinal diseases . This has been confirmed by the identification of mutations that result in cone-rod dystrophy [6,7] and Lebers congenital amaurosis [8-10]. In addition, a wide range of clinical retinal phenotypes have been associated with mutations in this gene [11-15].
The impetus for the present study arose from an ongoing project to identify and enable evaluation of candidate genes for the large number of inherited canine photoreceptor disorders for which causes have not yet been identified. To this end we identified canine CRX (cCRX) as a specifically attractive candidate for cloning and evaluation. In parallel, we undertook to identify other potential candidate genes using Representational Difference Analysis (RDA). RDA was used to find genes expressed differentially between normal canine retinas and retinas affected with cone degeneration (cd). One of the clones identified by RDA turned out to be the cCRX cDNA. We thus report here the cloning of cCRX by two different but complementary strategies, the characterization of its genomic organization, and its exclusion as the cause of canine cd in Alaskan malamutes, rod cone dysplasia type 2 (rcd2) in collies, and two different forms of early onset progressive retinal atrophy (PRA) affecting the American Staffordshire terrier and the Tibetan terrier, respectively.
Animals, pedigrees and samples
Blood samples were obtained from privately owned Tibetan terrier dogs affected with an autosomal recessive form of progressive retinal atrophy (PRA). This form of PRA is clinically evident by 1-1.5 years and progresses to complete blindness at a young age . Blood and tissue samples from all other dogs studied were obtained from the Retinal Disease Studies Facility (RDSF) colony maintained under the sponsorship of NEI/NIH grant EY-06855 (see below). Genomic DNA was isolated from citrated blood samples either by standard phenol/chloroform extraction, or a rapid protocol described previously .
To enable identification of potential retinal degeneration genes by RDA, normal canine retinas and retinas from cd affected dogs [18-20] were obtained from the RDSF colony. Blood, retinal and other tissue samples were also obtained from 2 other strains of dogs from the RDSF colony. Each such strain represented a different canine pedigree segregating a phenotypically distinct retinal disease. The rcd2 strain segregates an autosomal recessive rod-cone defect originally derived from collie dogs [21,22]. The other strain segregates a different autosomal recessive early onset retinal degeneration derived from the American Staffordshire terrier breed. The latter disease is as yet incompletely characterized, but affected animals have severe visual impairment by 6 months of age which progresses rapidly to total blindness (Acland and Aguirre, unpublished). All procedures involving animals were done in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Isolation of RNA, cDNA synthesis, and cDNA Representational Difference Analysis (RDA)
Total RNA was isolated from normal and cd affected canine retinas, both samples from animals 2 years of age, using RNAzol B (Tel-Test Inc., Friendswood, TX). At 2 years of age, the cd affected retinas would have nearly complete loss of cones, thus enriching for cone transcripts that would be expressed in the normal retina. Poly(A)+ RNAs were fractionated from total RNA by two successive rounds on oligo(dT)-cellulose columns (Amersham Pharmacia Biotech Inc., Piscataway, NJ). First strand cDNA synthesis was performed with Super Script II reverse transcriptase (Invitrogen, Carlsbad, CA) using 2 mg of mRNA and 1 mg of oligo(dT) primer. Then the first strand cDNA was used as a template to create the second strand cDNA, as described in the manufacturer's protocol (Life Technologies Inc., Gaithersburg, MD).
Generation of fragments for RDA was carried out according to the protocol of Hubank and Schatz , and based on genomic representational difference analysis . Double stranded cDNA (4 mg) was digested with DpnII and amplified cDNA fragments (amplicons) were obtained using different sets of primers: R-Bgl-12 (GAT CTG CGG TGA), R-Bgl-24 (AGC ACT CTC CAG CCT CTC), J-Bgl-12 (GAT CTG TTC ATG), J-Bgl-24 (ACC GAC GTC GAC TAT CCA TGA ACA), N-Bgl-12 (GAT CTT CCC TCG), and N-Bgl-24 (AGG CAA CTG TGC TAT CCG AGG GAA). Three rounds of subtractive hybridization were performed and the RDA products were digested with DpnII and ligated to pBluescript KS II+ (Stratagene, La Jolla, CA). Sequence of the cDNA inserts was determined using the Thermo Sequenase II dye terminator cycle sequencing kit (Amersham Pharmacia Biotech Inc., Piscataway, NJ).
Genomic and cDNA Cloning
In order to obtain complete genomic sequence coverage of cCRX, forward consensus primer crx12 from exon I was used in combination with consensus reverse primer crx-8 from exon III in a PCR reaction on 100 ng of genomic DNA. (Figure 1). The resulting PCR product was purified using the QiaexII gel extraction kit (Qiagen, Chatsworth, CA), and cloned using the TA Cloning kit (Invitrogen, San Diego, CA). Vector primers T7 and pcrII-1 were used to obtain the 5' and 3' sequences of the genomic clone. Exonic primers designed from consensus sequences were used to sequence the CRX clone in order to establish intron sizes; intronic primers were designed from the canine clone sequence to give full genomic sequence coverage of CRX. In order to obtain 5'UTR sequence, exon I reverse primer crx-3 was used with vector primer pBK-III in a PCR reaction with DNA extracted from a custom canine retinal cDNA library (Stratagene, La Jolla, CA). The resulting PCR product was cloned (as above) and sequenced using vector specific primers. Sequencing in an Applied Biosystems ABI 377 automated DNA sequencer at the core sequencing facility of Cornell University verified the authenticity of the CRX clones. Table 1 gives details on primer sequences and PCR conditions used for genomic cloning of cCRX.
Radiation hybrid (RH) mapping
Exonic consensus primers were designed from CRX cDNA sequences available in GenBank for mouse, rat, bovine, and human. A forward primer (crx-6) from exon II was used in a canine genomic PCR reaction with a reverse primer (crx-7) designed from exon III. The resulting PCR product of 1200 nucleotides was purified using the QiaexII gel extraction kit, eluted in water, and sequenced using the crx-6 primer in the sequencing reaction. From the resulting sequence, two intronic primers from intron II, crx-13 and crx-14, were designed to produce a canine specific PCR product of 174 base pairs (Table 1). The crx-13 and crx-14 primers were tested on canine, hamster, and 5:1 hamster/canine DNA under universal conditions (94 °C (20 s), 58 °C (20 s), 74 °C (20 s); 30 cycles, 2.0 mM Mg2+, DNA 50 ng/ml)  for use on a whole genome dog/hamster RH3000 panel (92 RH cell RH083000, Research Genetics, Inc., Huntsville, AL). To establish linkage to CFA1, we amplified five markers (VASP, FH2634, C5RI, LHB and FH2326) previously published for the region of interest . In addition we used primers FH3505-f (5' ACTGGCCAAAGAGTACAAGG 3') and FH3505-r (5' AGTCATGCTGATTTCTGTGC 3') to add marker FH3505 to the canine RH map. The map was constructed using Multimap software  based on best two point analysis, placing markers at Lod score 2.0 for overall order.
Isolation and characterization of cCRX cDNA by RDA and library screening
The different cDNA fragments obtained from RDA/PCR amplification of mRNAs from normal and cd dog retinas were subcloned into the pCR II cloning vector (Invitrogen). Through sequence analysis and Genbank database search, one of these fragments was found to have a high degree of identity to the published human and mouse CRX cDNA. This fragment was subsequently used to screen approximately 100,000 plaques from a custom made canine retinal cDNA library (Stratagene). Two positive clones were identified, containing insert sizes of 2.2 and 3.4 kb. The longer insert contained the entire sequence of the canine CRX cDNA with an unusually long 3' untranslated region (UTR) of 2297 bp, 102 bp of the 5' UTR, as well as the open reading frame of 900 bp encoding a protein of 299 amino acids. This sequence is similar to that obtained by cDNA library screening and cloning. The complete cCRX cDNA sequence was compiled by overlaying sequence data from the two different strategies used, and the contig represented consensus sequence information (GenBank accession number AF454668). Alignment of amino acid sequences of cCRX with those of bovine, human, rat and mouse showed a high degree of homology between these species with complete conservation of the homeodomain (Figure 2).
Characterization of genomic cCRX
Determination of the genomic organization of the canine CRX gene was done by PCR with primers designed from the canine sequence (Table 1). The positions of the exon and intron splice junctions, and the primers used are shown in Figure 1. Comparative analysis of the cCRX genomic and cDNA sequences revealed that the gene structure consists of three exons and two introns. The 5'-UTR and protein initiation codon as well as amino acids 2-34 are found in exon 1. Exon 2 contains the cDNA sequence encoding 50 aa residues from 35 to 84. Exon 3 spans the remaining 215 aa, and contains the entire 3'-UTR sequence. The sizes of the two introns are 789 and 1059 bp, respectively.
Radiation hybrid mapping
RH mapping using the RH083000 canine-hamster panel placed cCRX on the telomeric end of CFA1, in a position approximately 113.6 cR3000 telomeric to the tetranucleotide microsatellite FH2326, and 31.7 cR3000 centromeric to the tetranucleotide microsatellite FH2634 (Figure 3). Even though CRX and marker FH3505 have not been previously mapped in the dog, our RH3000 map is in complete agreement with the most recent publication of the CNRS RHDF5000 canine radiation hybrid map . This region exhibits conserved synteny with HSA19q13-q13.3, and is thus in accord with human mapping data which localizes CRX to HSA19q13.
Evaluation of cCRX as a candidate for inherited photoreceptor degeneration
Cone degeneration in the Alaskan malamute
The mapping of cCRX to CFA1 excluded this gene as a candidate for cd. In other studies (Acland et al., unpublished), we had previously observed multiple recombinations between cd and markers FH2309, AHT138, C01.643, C01.164, FH2326, and FH2294 which have been mapped to CFA 1 . This effectively excludes the entire interval flanking cCRX from association with the disease. In addition, northern blot hybridization of a CRX cDNA probe to canine retinal RNA from normal (16 weeks of age) and cd affected (6 weeks of age) animals showed no detectable transcriptional differences (data not shown).
rcd2 in the collie
The sequence of the normal canine CRX was compared to that of the rcd2 affected dogs. Full length genomic clones and overlapping PCR products were sequenced in both directions to provide full genomic coverage of the gene. No differences in the sequence were observed between the normal and affected. Linkage analysis in an rcd2 pedigree informative for FH2634 demonstrated 2 recombinants among 4 informative dogs in a phase known pedigree (Figure 4A). The normal genomic sequencing and identification of 2 of 4 recombinations in a marker physically proximate to CRX effectively rules out the gene from causal association with the disease.
Early onset retinal degeneration in the American Staffordshire terrier
Genomic analysis indicated no sequence differences between normal and affected American Staffordshire terriers. Microsatellites FH2326 and FH2634 were informative for linkage analysis in the pedigree. These markers flank CRX and are tightly linked to each other with no recombinations. Identifying 2 recombinant animals in the small subset pedigree effectively excludes CRX as the disease causing gene (Figure 4B).
PRA in the Tibetan terrier
The small number of animals available for study did not constitute a pedigree that could be used to examine for co-segregation between a polymorphism within markers flanking CRX and the disease. As an alternative strategy, we used genomic sequencing of the cCRX gene from a PRA affected Tibetan terrier, and compared the sequence obtained with that of normal. No differences were found, indicating the presumptive exclusion of this gene.
In this study, we examined cCRX as a potential disease causing gene for inherited retinal disorders in the dog. Initially, we isolated and characterized the cCRX cDNA, determined its genomic structure and compared it with published mammalian orthologs (GenBank accession numbers: AF154123, AF024711, AF135838, NM_007770). Sequence comparison revealed that the most divergent region of the CRX cDNAs is in the 3'-UTR which is unusually long, and has several cytidine rich (C-rich) segments.
Because CRX plays a critical role in early photoreceptor development and differentiation, we evaluated it as a candidate gene in a set of canine early onset diseases. These affect the rods and/or cones, and are phenotypically comparable to those which occur in man and result from mutations in CRX [1,6-10]. As part of a specific effort to identify potential candidates for canine cd, we isolated clones by cDNA representational difference analysis between age matched normal and cd affected retinas. Among the clones isolated, we identified a cCRX transcript. However, linkage data already in hand (Acland et al., unpublished) which showed multiple recombinations to markers located in regions flanking cCRX  effectively and formally excludes cd from this entire interval on CFA1.
In addition, no abnormalities in the CRX sequence were found by comparing the exon sequences of normal dogs with those from dogs affected with rcd2 (collies), or early onset forms of PRA (American Staffordshire terrier, Tibetan terrier). This excludes coding and splicing mutations of CRX from involvement in the disease, but does not formally exclude the gene. However, by using markers close to CRX on CFA1 for linkage analysis, the candidate gene was excluded by finding multiple recombinants in the rcd2 and American Staffordshire terrier pedigrees. As multiple other genes and loci are associated with early onset rod and/or cone disease (RetNet), the exclusion of CRX from these four canine diseases is not surprising. Now that resources for linkage and physical mapping of disease traits are available for dogs [26,28,29], it will be possible to use the disease informative pedigrees to carry out genome wide scans. These will allow the use of comparative genomic approaches to identify the disease causing genes and mutations present in these important animal models.
Supported by NEI/NIH grants EY06855, EY13132 and EY08285; Foundation Fighting Blindness; Morris Animal Foundation/The Seeing Eye, Inc.; the American Kennel Club-Canine Health Foundation; the Van Sloun Fund for Canine Genetic Research, the Baker Institute Inherited Eye Disease Gift Fund, and the Cornell University Center for Biotechnology, a New York State Office of Science, Technology and Academic Research (NYSTAR) designated center for advanced technology. DBF is the recipient of a Research to Prevent Blindness Senior Scientific Investigators Award. CM was a Ralson Purina postdoctoral fellow. The authors are grateful to Drs. C. Freund and R. McInnes for helpful discussions, and the staff of the RDSF for the breeding and care of the experimental dogs.
1. Furukawa T, Morrow EM, Cepko CL. Crx, a novel otx-like homeobox gene, shows photoreceptor specific expression and regulates photoreceptor differentiation. Cell 1997; 91:531-41.
2. Chen S, Wang QL, Nie Z, Sun H, Lennon G, Copeland NG, Gilbert DJ, Jenkins NA, Zack DJ. Crx, a novel Otx-like paired-homeodomain protein, binds to and transactivates photoreceptor cell-specific genes. Neuron 1997; 19:1017-30.
3. Livesey FJ, Furukawa T, Steffen MA, Church GM, Cepko CL. Microarray analysis of the transcriptional network controlled by the photoreceptor homeobox gene Crx. Curr Biol 2000; 10:301-10.
4. Mitton KP, Swain PK, Chen S, Xu S, Zack DJ, Swaroop A. The leucine zipper of NRL interacts with the CRX homeodomain. A possible mechanism of transcriptional synergy in rhodopsin regulation. J Biol Chem 2000; 275:29794-9.
5. Chau KY, Munshi N, Keane-Myers A, Cheung-Chau KW, Tai AK, Manfioletti G, Dorey CK, Thanos D, Zack DJ, Ono SJ. The architectural transcription factor high mobility group I(Y) participates in photoreceptor specific gene expression. J Neurosci 2000; 20:7317-24.
6. Freund CL, Gregory-Evans CY, Furukawa T, Papaioannou M, Looser J, Ploder L, Bellingham J, Ng D, Herbrick JA, Duncan A, Scherer SW, Tsui LC, Loutradis-Anagnostou A, Jacobson SG, Cepko CL, Bhattacharya SS, McInnes RR. Cone-rod dystrophy due to mutations in a novel photoreceptor specific homeobox gene (CRX) essential for maintenance of the photoreceptor. Cell 1997; 91:543-53.
7. Swain PK, Chen S, Wang QL, Affatigato LM, Coats CL, Brady KD, Fishman GA, Jacobson SG, Swaroop A, Stone E, Sieving PA, Zack DJ. Mutations in the cone-rod homeobox gene are associated with the cone-rod dystrophy photoreceptor degeneration. Neuron 1997; 19:1329-936.
8. Freund CL, Wang QL, Chen S, Muskat BL, Wiles CD, Sheffield VC, Jacobson SG, McInnes RR, Zack DJ, Stone EM. De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis. Nat Genet 1998; 18:311-2.
9. Swaroop A, Wang QL, Wu W, Cook J, Coats C, Xu S, Chen S, Zack DJ, Sieving PA. Leber congenital amaurosis caused by a homozygous mutation (R90W) in the homeodomain of the retinal transcription factor CRX: direct evidence for the involvement of CRX in the development of photoreceptor function. Hum Mol Genet 1999; 8:299-305.
10. Silva E, Yang JM, Li Y, Dharmaraj S, Sundin OH, Maumenee IH. A CRX null mutation is associated with both Leber congenital amaurosis and a normal ocular phenotype. Invest Ophthalmol Vis Sci 2000; 41:2076-9.
11. Sohocki MM, Sullivan LS, Mintz-Hittner HA, Birch D, Heckenlively JR, Freund CL, McInnes RR, Daiger SP. A range of clinical phenotypes associated with mutations in CRX, a photoreceptor transcription-factor gene. Am J Hum Genet 1998; 63:1307-15.
12. Jacobson SG, Cideciyan AV, Huang Y, Hanna DB, Freund CL, Affatigato LM, Carr RE, Zack DJ, Stone EM, McInnes RR. Retinal degenerations with truncation mutations in the cone-rod homeobox (CRX) gene. Invest Ophthalmol Vis Sci 1998; 39:2417-26.
13. Tzekov RT, Sohocki MM, Daiger SP, Birch DG. Visual phenotype in patients with Arg41Gln and Ala196+1bp mutations in the CRX gene. Ophthalmic Genet 2000; 21:89-99.
14. Sankila EM, Joensuu TH, Hamalainen RH, Raitanen N, Valle O, Ignatius J, Cormand B. A CRX mutation in a Finnish family with dominant cone-rod retinal dystrophy. Hum Mutat 2000; 16:94.
15. Tzekov RT, Liu Y, Sohocki MM, Zack DJ, Daiger SP, Heckenlively JR, Birch DG. Autosomal dominant retinal degeneration and bone loss in patients with a 12-bp deletion in the CRX gene. Invest Ophthalmol Vis Sci 2001; 42:1319-27.
16. Millichamp NJ, Curtis R, Barnett KC. Progressive retinal atrophy in Tibetan terriers. J Am Vet Med Assoc 1988; 192:769-76.
17. Ray K, Acland GM, Aguirre GD. Nonallelism of erd and prcd and exclusion of the canine RDS/peripherin gene as a candidate for both retinal degeneration loci. Invest Ophthalmol Vis Sci 1996; 37:783-94.
18. Aguirre GD, Rubin LF. Pathology of hemeralopia in the Alaskan malamute dog. Invest Ophthalmol 1974; 13:231-5.
19. Aguirre GD, Rubin LF. The electroretinogram in dogs with inherited cone degeneration. Invest Ophthalmol 1975; 14:840-7.
20. Gropp KE, Szel A, Huang JC, Acland GM, Farber DB, Aguirre GD. Selective absence of cone outer segment beta 3-transducin immunoreactivity in hereditary cone degeneration (cd). Exp Eye Res 1996; 63:285-96.
21. Santos-Anderson RM, Tso MO, Wolf ED. An inherited retinopathy in collies. A light and electron microscopic study. Invest Ophthalmol Vis Sci 1980; 19:1281-94.
22. Woodford BJ, Liu Y, Fletcher RT, Chader GJ, Farber DB, Santos-Anderson R, Tso MO. Cyclic nucleotide metabolism in inherited retinopathy in collies: a biochemical and histochemical study. Exp Eye Res 1982; 34:703-14.
23. Hubank M, Schatz DG. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 1994; 22:5640-8.
24. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993; 259:946-51.
25. Priat C, Hitte C, Vignaux F, Renier C, Jiang Z, Jouquand S, Cheron A, Andre C, Galibert F. A whole-genome radiation hybrid map of the dog genome. Genomics 1998; 54:361-78.
26. Mellersh CS, Hitte C, Richman M, Vignaux F, Priat C, Jouquand S, Werner P, Andre C, DeRose S, Patterson DF, Ostrander EA, Galibert F. An integrated linkage-radiation hybrid map of the canine genome. Mamm Genome 2000; 11:120-30.
27. Matise TC, Perlin M, Chakravarti A. Automated construction of genetic linkage maps using an expert system (Multimap): a human genome linkage map. Nat Genet 1994; 6:384-90.
28. Breen M, Jouquand S, Renier C, Mellersh CS, Hitte C, Holmes NG, Cheron A, Suter N, Vignaux F, Bristow AE, Priat C, McCann E, Andre C, Boundy S, Gitsham P, Thomas R, Bridge WL, Spriggs HF, Ryder EJ, Curson A, Sampson J, Ostrander EA, Binns MM, Galibert F. Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker integrated radiation-hybrid/linkage map of the domestic dog genome to all chromosomes. Genome Res 2001; 11:1784-95.
29. Li R, Mignot E, Faraco J, Kadotani H, Cantanese J, Zhao B, Lin X, Hinton L, Ostrander EA, Patterson DF, de Jong PJ. Construction and characterization of an eightfold redundant dog genomic bacterial artificial chromosome library. Genomics 1999; 58:9-17.